1
|
Ravi Kiran AVVV, Kumari GK, Krishnamurthy PT, Johnson AP, Kenchegowda M, Osmani RAM, Abu Lila AS, Moin A, Gangadharappa HV, Rizvi SMD. An Update on Emergent Nano-Therapeutic Strategies against Pediatric Brain Tumors. Brain Sci 2024; 14:185. [PMID: 38391759 PMCID: PMC10886772 DOI: 10.3390/brainsci14020185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Revised: 02/07/2024] [Accepted: 02/13/2024] [Indexed: 02/24/2024] Open
Abstract
Pediatric brain tumors are the major cause of pediatric cancer mortality. They comprise a diverse group of tumors with different developmental origins, genetic profiles, therapeutic options, and outcomes. Despite many technological advancements, the treatment of pediatric brain cancers has remained a challenge. Treatment options for pediatric brain cancers have been ineffective due to non-specificity, inability to cross the blood-brain barrier, and causing off-target side effects. In recent years, nanotechnological advancements in the medical field have proven to be effective in curing challenging cancers like brain tumors. Moreover, nanoparticles have emerged successfully, particularly in carrying larger payloads, as well as their stability, safety, and efficacy monitoring. In the present review, we will emphasize pediatric brain cancers, barriers to treating these cancers, and novel treatment options.
Collapse
Affiliation(s)
- Ammu V V V Ravi Kiran
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Rocklands, Ooty 643001, The Nilgiris, Tamil Nadu, India
| | - G Kusuma Kumari
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Rocklands, Ooty 643001, The Nilgiris, Tamil Nadu, India
| | - Praveen T Krishnamurthy
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Rocklands, Ooty 643001, The Nilgiris, Tamil Nadu, India
| | - Asha P Johnson
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India
| | - Madhuchandra Kenchegowda
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India
| | - Riyaz Ali M Osmani
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India
| | - Amr Selim Abu Lila
- Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia
| | - Afrasim Moin
- Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia
| | - H V Gangadharappa
- Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India
| | - Syed Mohd Danish Rizvi
- Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia
| |
Collapse
|
2
|
Abedin S, Adeleke OA. State of the art in pediatric nanomedicines. Drug Deliv Transl Res 2024:10.1007/s13346-024-01532-x. [PMID: 38324166 DOI: 10.1007/s13346-024-01532-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2024] [Indexed: 02/08/2024]
Abstract
In recent years, the continuous development of innovative nanopharmaceuticals is expanding their biomedical and clinical applications. Nanomedicines are being revolutionized to circumvent the limitations of unbound therapeutic agents as well as overcome barriers posed by biological interfaces at the cellular, organ, system, and microenvironment levels. In many ways, the use of nanoconfigured delivery systems has eased challenges associated with patient differences, and in our opinion, this forms the foundation for their potential usefulness in developing innovative medicines and diagnostics for special patient populations. Here, we present a comprehensive review of nanomedicines specifically designed and evaluated for disease management in the pediatric population. Typically, the pediatric population has distinguishing needs relative to those of adults majorly because of their constantly growing bodies and age-related physiological changes, which often need specialized drug formulation interventions to provide desirable therapeutic effects and outcomes. Besides, child-centric drug carriers have unique delivery routes, dosing flexibility, organoleptic properties (e.g., taste, flavor), and caregiver requirements that are often not met by traditional formulations and can impact adherence to therapy. Engineering pediatric medicines as nanoconfigured structures can potentially resolve these limitations stemming from traditional drug carriers because of their unique capabilities. Consequently, researchers from different specialties relentlessly and creatively investigate the usefulness of nanomedicines for pediatric disease management as extensively captured in this compilation. Some examples of nanomedicines covered include nanoparticles, liposomes, and nanomicelles for cancer; solid lipid and lipid-based nanostructured carriers for hypertension; self-nanoemulsifying lipid-based systems and niosomes for infections; and nanocapsules for asthma pharmacotherapy.
Collapse
Affiliation(s)
- Saba Abedin
- College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, NS, B3H 4R2, Canada
| | - Oluwatoyin A Adeleke
- College of Pharmacy, Faculty of Health, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
| |
Collapse
|
3
|
Das P, Pujals S, Ali LMA, Gary-Bobo M, Albertazzi L, Durand JO. Super-resolution imaging of antibody-conjugated biodegradable periodic mesoporous organosilica nanoparticles for targeted chemotherapy of prostate cancer. NANOSCALE 2023; 15:12008-12024. [PMID: 37403617 DOI: 10.1039/d3nr01571h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/06/2023]
Abstract
Biodegradable periodic mesoporous organosilica nanoparticles (nanoPMOs) are widely used as responsive drug delivery platforms for targeted chemotherapy of cancer. However, the evaluation of their properties such as surface functionality and biodegradability is still challenging, which has a significant impact on the efficiency of chemotherapy. In this study, we have applied direct stochastic optical reconstruction microscopy (dSTORM), a single-molecule super-resolution microscopy technique, to quantify the degradation of nanoPMOs triggered by glutathione and the multivalency of antibody-conjugated nanoPMOs. Subsequently, the effect of these properties on cancer cell targeting, drug loading and release capability, and anticancer activity is also studied. Due to the higher spatial resolution at the nanoscale, dSTORM imaging is able to reveal the structural properties (i.e., size and shape) of fluorescent and biodegradable nanoPMOs. The quantification of nanoPMOs' biodegradation using dSTORM imaging demonstrates their excellent structure-dependent degradation behavior at a higher glutathione concentration. The surface functionality of anti-M6PR antibody-conjugated nanoPMOs as quantified by dSTORM imaging plays a key role in prostate cancer cell labeling: oriented antibody is more effective than random ones, while high multivalency is also effective. The higher biodegradability and cancer cell-targeting properties of nanorods conjugated with oriented antibody (EAB4H) effectively deliver the anticancer drug doxorubicin to cancer cells, exhibiting potent anticancer effects.
Collapse
Affiliation(s)
- Pradip Das
- Institute Charles Gerhardt Montpellier (ICGM), University of Montpellier, CNRS, ENSCM, Montpellier 34293, France.
- Nanoscopy for Nanomedicine Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona 08036, Spain
| | - Silvia Pujals
- Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
| | - Lamiaa M A Ali
- IBMM, University of Montpellier, CNRS, ENSCM, 34093 Montpellier, France
| | - Magali Gary-Bobo
- IBMM, University of Montpellier, CNRS, ENSCM, 34093 Montpellier, France
| | - Lorenzo Albertazzi
- Nanoscopy for Nanomedicine Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona 08036, Spain
- Department of Biomedical Engineering, Institute of Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands
| | - Jean-Olivier Durand
- Institute Charles Gerhardt Montpellier (ICGM), University of Montpellier, CNRS, ENSCM, Montpellier 34293, France.
| |
Collapse
|
4
|
Omidian H, Mfoafo K. Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions. Pharmaceutics 2023; 15:1583. [PMID: 37376032 DOI: 10.3390/pharmaceutics15061583] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Revised: 05/18/2023] [Accepted: 05/22/2023] [Indexed: 06/29/2023] Open
Abstract
The utilization of nanotechnology has brought about notable advancements in the field of pediatric medicine, providing novel approaches for drug delivery, disease diagnosis, and tissue engineering. Nanotechnology involves the manipulation of materials at the nanoscale, resulting in improved drug effectiveness and decreased toxicity. Numerous nanosystems, including nanoparticles, nanocapsules, and nanotubes, have been explored for their therapeutic potential in addressing pediatric diseases such as HIV, leukemia, and neuroblastoma. Nanotechnology has also shown promise in enhancing disease diagnosis accuracy, drug availability, and overcoming the blood-brain barrier obstacle in treating medulloblastoma. It is important to acknowledge that while nanotechnology offers significant opportunities, there are inherent risks and limitations associated with the use of nanoparticles. This review provides a comprehensive summary of the existing literature on nanotechnology in pediatric medicine, highlighting its potential to revolutionize pediatric healthcare while also recognizing the challenges and limitations that need to be addressed.
Collapse
Affiliation(s)
- Hossein Omidian
- College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA
| | - Kwadwo Mfoafo
- College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA
| |
Collapse
|
5
|
Manukonda R, Narayana RV, Kaliki S, Mishra DK, Vemuganti GK. Emerging therapeutic targets for retinoblastoma. Expert Opin Ther Targets 2022; 26:937-947. [PMID: 36524402 DOI: 10.1080/14728222.2022.2158812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
INTRODUCTION Retinoblastoma (Rb) is an early childhood intraocular tumor of the retina and is managed by multimodal therapeutic approaches. Recent advanced targeted delivery of chemotherapeutic drugs to the eye has improved the possibility of globe salvage. However, enucleation is inevitable for advanced and recurrent Rb. The cumulative knowledge of identification of newer molecular biology tools, exosomal cargo, role of cancer stem cells (CSCs), and its microenvironment in the progression of the diseases warrants a relook at the traditional treatment protocol and explore the feasibility of targeted therapies. AREAS COVERED This review covers Rb pathobiology, novel molecular-targeted therapeutics, and strategies targeting Rb CSCs and provides an update on potential therapeutic targets such as second messengers and exosomal cargo. EXPERT OPINION The emergence of early diagnosis and multimodality treatment protocols have significantly improved the clinical outcome of children with advanced Rb; however, the problem of tumor recurrence has not yet been overcome. Improved understanding of the molecular pathways, identification, and characterization of CSCs opens up new targeted therapy approaches. The contemporary evidence from other fields shows promising evidence that combining conservative treatment modalities with targeting therapies specific for CSCs in clinical practice is essential for achieving high globe salvage rate in Rb patients.
Collapse
Affiliation(s)
- Radhika Manukonda
- The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.,Brien Holden Eye Research Center, L. V. Prasad Eye Institute, Hyderabad, India
| | - Revu Vl Narayana
- School of Medical Sciences, University of Hyderabad, Science Complex, Hyderabad, India
| | - Swathi Kaliki
- The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.,Brien Holden Eye Research Center, L. V. Prasad Eye Institute, Hyderabad, India
| | - Dilip K Mishra
- Ophthalmic Pathology Laboratory, LV Prasad Eye Institute, Hyderabad, India
| | - Geeta K Vemuganti
- School of Medical Sciences, University of Hyderabad, Science Complex, Hyderabad, India
| |
Collapse
|
6
|
Nanotechnology for Pediatric Retinoblastoma Therapy. Pharmaceuticals (Basel) 2022; 15:ph15091087. [PMID: 36145308 PMCID: PMC9504930 DOI: 10.3390/ph15091087] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Revised: 08/26/2022] [Accepted: 08/27/2022] [Indexed: 12/11/2022] Open
Abstract
Retinoblastoma is a rare, sometimes hereditary, pediatric cancer. In high-income countries this disease has a survival rate approaching 100%, while in low- and middle-income countries the prognosis is fatal for about 80% of cases. Depending on the stage of the disease, different therapeutic protocols are applied. In more advanced forms of the disease, surgical removal of the entire globe and its intraocular contents (enucleation) is, unfortunately, necessary, whereas in other cases, conventional chemotherapy is normally used. To overcome the side-effects and reduced efficacy of traditional chemotherapic drugs, nanodelivery systems that ensure a sustained drug release and manage to reach the target site have more recently been developed. This review takes into account the current use and advances of nanomedicine in the treatment of retinoblastoma and discusses nanoparticulate formulations that contain conventional drugs and natural products. In addition, future developments in retinoblastoma treatment are discussed.
Collapse
|
7
|
N’Diaye M, Vergnaud-Gauduchon J, Nicolas V, Faure V, Denis S, Abreu S, Chaminade P, Rosilio V. Hybrid Lipid Polymer Nanoparticles for Combined Chemo- and Photodynamic Therapy. Mol Pharm 2019; 16:4045-4058. [DOI: 10.1021/acs.molpharmaceut.9b00797] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Affiliation(s)
- Marline N’Diaye
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Juliette Vergnaud-Gauduchon
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Valérie Nicolas
- UMS IPSIT, Univ Paris-Sud, US 31 INSERM, UMS 3679 CNRS, Microscopy Facility, 92290 Châtenay-Malabry, France
| | - Victor Faure
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Stéphanie Denis
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Sonia Abreu
- Lip(Sys)2, Chimie Analytique Pharmaceutique, Univ Paris-Sud, Université Paris-Saclay, F-92290 Chistenay-Malabry Cedex, France
| | - Pierre Chaminade
- Lip(Sys)2, Chimie Analytique Pharmaceutique, Univ Paris-Sud, Université Paris-Saclay, F-92290 Chistenay-Malabry Cedex, France
| | - Véronique Rosilio
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| |
Collapse
|
8
|
Daghildjian K, Kasselouri A, N’Diaye M, Michel JP, Vergnaud J, Poyer F, Maillard P, Rosilio V. Mannose distribution in glycoconjugated tetraphenylporphyrins governs their uptake mechanism and phototoxicity. J PORPHYR PHTHALOCYA 2019. [DOI: 10.1142/s1088424619500184] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Tetraphenylporphyrins (TPPs) have been proposed for the treatment of retinoblastoma by photodynamic therapy. Glycoconjugated compounds were synthesized for improving TPP solubility and amphipathy, and to specifically target mannose receptors overexpressed at the surface of cells. The efficiency of four TPP derivatives with different chemical structures was compared by phototoxicity tests and flow cytometry experiments. Interestingly, the absence/presence and distribution of saccharide moieties in the various compounds affected differently their mechanism of interaction with cancer cells and their phototoxic efficiency. For glycodendrimeric TPP-1 and TPP-2 incubated with retinoblastoma cells, a fast two-step uptake-equilibrium process was observed, whereas for a dendrimeric TPP without saccharide moieties (TPP-1c) and a glycoconjugated compound with no dendrimeric structure (TPP(DegMan)[Formula: see text] uptake was very slow. The difference in uptake profiles and kinetics between TPP-1c on the one hand and TPP-1 and TPP-2 on the other hand would account for the interaction of the two glycodendrimeric compounds with a mannose receptor. These TPPs encapsulated in endosomes would induce less damage to cells upon illumination. TPP(DegMan)[Formula: see text] showed the highest phototoxicity, but its efficiency was unaffected by pretreatment of cells by mannan. The penetration of this glycoconjugated compound in cells and its phototoxic effect appeared independent of its interaction with a mannose receptor. Thus, if glycoconjugation influenced TPPs behavior in solution and interaction with serum proteins, phototoxicity was not necessarily related to upfront molecular recognition.
Collapse
Affiliation(s)
- Katia Daghildjian
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Athena Kasselouri
- Lip(Sys)2, Chimie Analytique Pharmaceutique, Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry Cedex, France
| | - Marline N’Diaye
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Jean-Philippe Michel
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Juliette Vergnaud
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| | - Florent Poyer
- Institut Curie, Research Center, PSL Research University, CNRS, INSERM, UMR 9187, U 1196, Chemistry, Modelling and Imaging for Biology (CMIB), Université Paris-Sud, Université Paris-Saclay, Bât 110-112, Centre Universitaire, F-91405 Orsay Cedex, France
| | - Philippe Maillard
- Institut Curie, Research Center, PSL Research University, CNRS, INSERM, UMR 9187, U 1196, Chemistry, Modelling and Imaging for Biology (CMIB), Université Paris-Sud, Université Paris-Saclay, Bât 110-112, Centre Universitaire, F-91405 Orsay Cedex, France
| | - Véronique Rosilio
- Institut Galien Paris Sud, UMR 8612, Univ Paris-Sud, CNRS, Université Paris-Saclay, 5 rue J.B. Clément, F-92290 Châtenay-Malabry, France
| |
Collapse
|
9
|
Qi M, Darviot C, Patskovsky S, Meunier M. Cost-effective side-illumination darkfield nanoplasmonic marker microscopy. Analyst 2018; 144:1303-1308. [PMID: 30560253 DOI: 10.1039/c8an01891j] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
We present the development of an innovative technology for quantitative multiplexed cytology analysis based on the application of spectrally distinctive plasmonic nanoparticles (NPs) as optical probes and on cost-effective side-illumination multispectral darkfield microscopy (SIM) as the differential NP imaging method. SIM is based on lateral illumination by arrays of discrete color RGB light emitting diodes (LEDs) of spectrally adjusted plasmonic NPs and consecutive detection by the conventional CMOS color camera. We demonstrate the enhanced contrast and higher resolution of our method for individual NP detection in the liquid medium and of NP markers attached on the cell membrane in a cytology preparation by comparing it to the conventional darkfield microscopy (DFM). The proposed illumination and detection system is compatible with current clinical microscopy equipment used by pathologists and can greatly simplify the adaptation of plasmonic NPs as novel reliable and stable biological multiplexed chromatic markers for biodetection and diagnosis.
Collapse
Affiliation(s)
- Mengjiao Qi
- Engineering Physics Department, Ecole Polytechnique de Montréal, Laser Processing and Plasmonics Laboratory, Montréal, Québec H3C 3A7, Canada.
| | - Cecile Darviot
- Engineering Physics Department, Ecole Polytechnique de Montréal, Laser Processing and Plasmonics Laboratory, Montréal, Québec H3C 3A7, Canada.
| | - Sergiy Patskovsky
- Engineering Physics Department, Ecole Polytechnique de Montréal, Laser Processing and Plasmonics Laboratory, Montréal, Québec H3C 3A7, Canada.
| | - Michel Meunier
- Engineering Physics Department, Ecole Polytechnique de Montréal, Laser Processing and Plasmonics Laboratory, Montréal, Québec H3C 3A7, Canada.
| |
Collapse
|
10
|
Essaid D, Tfayli A, Maillard P, Sandt C, Rosilio V, Baillet-Guffroy A, Kasselouri A. Retinoblastoma membrane models and their interactions with porphyrin photosensitisers: An infrared microspectroscopy study. Chem Phys Lipids 2018; 215:34-45. [PMID: 30026072 DOI: 10.1016/j.chemphyslip.2018.07.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2018] [Revised: 07/02/2018] [Accepted: 07/11/2018] [Indexed: 12/16/2022]
Abstract
Fourier Transform Infrared (FTIR) microspectroscopy was used to highlight the interactions between two photosensitisers (PS) of different geometries, TPPmOH4 and a glycoconjugated analogous, TPPDegMan, and lipid bilayers modelling retinoblastoma cell membranes. Retinoblastoma is a rare disease occurring in young infants, for whom conservative treatments may present harmful side-effects. Photodynamic therapy (PDT) is expected to induce less side-effects, as the photosensitiser is only activated when the tumour is illuminated. Since efficiency of the treatment relies on photosensitiser penetration in cancer cells, bilayers with three lipid compositions - pure SOPC, SOPC/SOPE/SOPS/Chol (56:23:11:10) and SOPC/SOPE/SOPS/Chol/CL (42:32:9:8:6) - were used as plasma and mitochondria model membranes. FTIR spectra showed that the interaction of the PSs with the lipid bilayers impacted the lipid organization of the latter, causing significant spectral variations. Both studied photosensitisers inserted at the level of lipid hydrophobic chains, increasing chain fluidity and disorder. This was confirmed by surface pressure measurements. Photosensitisers - TPPmOH4 more than TPPDegMan - also interacted with the polar region of the bilayer, forming hydrogen bonds with phosphate groups that induced major shifts of phosphate absorption bands. This difference in PS interaction with moieties in the polar region was more pronounced with the models with complex lipid composition.
Collapse
Affiliation(s)
- Donia Essaid
- Lip(Sys)(2), Chimie Analytique Pharmaceutique, Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry cedex, France
| | - Ali Tfayli
- Lip(Sys)(2), Chimie Analytique Pharmaceutique, Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry cedex, France
| | - Philippe Maillard
- Department Chemistry, Modelling and Imaging for Biology (CMIB), Institut Curie, Research center, PSL Research University, Bât 110-112, Centre Universitaire, F-91405 Orsay cedex, France; CNRS, INSERM, UMR 9187-U 1196, Université Paris-Saclay, Univ. Paris-Sud, Bât 110-112, Centre Universitaire, F-91405 Orsay Cedex, France
| | - Christophe Sandt
- SMIS Beamline, Synchrotron SOLEIL, Orme des merisiers, BP48, 91192 Gif-sur-Yvette, France
| | - Véronique Rosilio
- Institut Galien Paris Sud, Univ Paris-Sud, CNRS, Université Paris-Saclay, F-92290 Châtenay-Malabry cedex, France
| | - Arlette Baillet-Guffroy
- Lip(Sys)(2), Chimie Analytique Pharmaceutique, Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry cedex, France
| | - Athena Kasselouri
- Lip(Sys)(2), Chimie Analytique Pharmaceutique, Univ. Paris-Sud, Université Paris-Saclay, F-92290 Châtenay-Malabry cedex, France.
| |
Collapse
|
11
|
Chen S, Poyer F, Garcia G, Fiorini-Debuisschert C, Rosilio V, Maillard P. Amphiphilic Glycoconjugated Porphyrin Heterodimers as Two-Photon Excitable Photosensitizers: Design, Synthesis, Photophysical and Photobiological Studies. ChemistrySelect 2018. [DOI: 10.1002/slct.201703013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Affiliation(s)
- Su Chen
- Department Chemistry and Modelisation and Imaging for Biology (CMIB); Institut Curie, Research Center; PSL Research University, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
- CNRS UMR 9187 - INSERM U 1196; Université Paris-Saclay; Université Paris Sud 11, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
| | - Florent Poyer
- Department Chemistry and Modelisation and Imaging for Biology (CMIB); Institut Curie, Research Center; PSL Research University, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
- CNRS UMR 9187 - INSERM U 1196; Université Paris-Saclay; Université Paris Sud 11, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
| | - Guillaume Garcia
- Department Chemistry and Modelisation and Imaging for Biology (CMIB); Institut Curie, Research Center; PSL Research University, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
- CNRS UMR 9187 - INSERM U 1196; Université Paris-Saclay; Université Paris Sud 11, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
| | | | - Véronique Rosilio
- Institut Galien Paris Sud, CNRS UMR 8612; Université Paris Sud 11; Université Paris-Saclay; 5 rue J.-B. Clément F-92296 Châtenay-Malabry France
| | - Philippe Maillard
- Department Chemistry and Modelisation and Imaging for Biology (CMIB); Institut Curie, Research Center; PSL Research University, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
- CNRS UMR 9187 - INSERM U 1196; Université Paris-Saclay; Université Paris Sud 11, Bât 110-112, Centre Universitaire; Rue Henri Becquerel F-91405 Orsay Cedex France
| |
Collapse
|
12
|
Lupu M, Maillard P, Mispelter J, Poyer F, Thomas CD. A glycoporphyrin story: from chemistry to PDT treatment of cancer mouse models. Photochem Photobiol Sci 2018; 17:1599-1611. [DOI: 10.1039/c8pp00123e] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Glycoporphyrin: from bench to preclinical studies on PDX xenografted on mice.
Collapse
Affiliation(s)
- M. Lupu
- Institut Curie
- Research Center
- PSL Research University
- CNRS
- INSERM
| | - Ph. Maillard
- Institut Curie
- Research Center
- PSL Research University
- CNRS
- INSERM
| | - J. Mispelter
- Institut Curie
- Research Center
- PSL Research University
- CNRS
- INSERM
| | - F. Poyer
- Institut Curie
- Research Center
- PSL Research University
- CNRS
- INSERM
| | - C. D. Thomas
- Institut Curie
- Research Center
- PSL Research University
- CNRS
- INSERM
| |
Collapse
|
13
|
Cellular uptake and phototoxicity of glycoconjugated tetraphenylporphyrins usable in PDT of retinoblastoma. Photodiagnosis Photodyn Ther 2017. [DOI: 10.1016/j.pdpdt.2017.01.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|